I would think they would spread the three arms as uniformly as possible to take away any possible clinic and geographical effects/differences.
Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial, page-25
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $50.72K | 487.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 471705 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 22797 | 3 |
View Market Depth
| Last trade - 11.56am 01/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |